MKB+ invests €3m in Aeon Astron Europe

The new equity will be used to support the company's expansion plans, including the addition of seven labs and a clean room, as well as an increase in the number of staff. The funding will also support Aeon Astron throughout  preclinical and clinical trials in the Netherlands and worldwide.

The equity was sourced from Innovatiefonds MKB+, a fund launched by the Royal Association MKB-Nederland in 2012. The association supports SMEs and entrepreneurs in the Netherlands.

The funding was awarded by Maxime Verhagen, Dutch minister of economic affairs, agriculture and innovation.

Company
Leiden-based Aeon Astron Europe is a biotechnology company that produces artificial corneae made of fish scales. The company is located in the BioScience Park of the University of Leiden. It is wholly owned by the Taiwanese company BOBC (Body Organ Biomedical Corporation).

The product fills the gap between demand and supply of cornea transplants.

Aeon Astron currently employs six people, but wants to increase the number of workers to 25-50.

People
Michael Lai is CEO and Ingrid Voregel is vice president of Aeon Astron Europe. 

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Benelux
• Now researching
• Healthcare
• Early-stage
• Netherlands